These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18355133)

  • 21. Triamcinolone acetonide concentration of aqueous humor after decanted 20-mg intravitreal injection.
    Cheng L; Banker AS; Martin M; Kozak I; Freeman WR
    Ophthalmology; 2009 Jul; 116(7):1356-9. PubMed ID: 19450879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, characterization, and in vivo evaluation of triamcinolone acetonide microspheres after intravitreal administration.
    Zarei-Ghanavati S; Malaekeh-Nikouei B; Pourmazar R; Seyedi S
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):502-6. PubMed ID: 22537291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular toxicity of intravitreal clarithromycin.
    Unal M; Peyman GA; Liang C; Hegazy H; Molinari LC; Chen J; Brun S; Tarcha PJ
    Retina; 1999; 19(5):442-6. PubMed ID: 10546942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.
    Komarowska I; Heilweil G; Rosenfeld PJ; Perlman I; Loewenstein A
    Retina; 2009 Jan; 29(1):98-105. PubMed ID: 18626418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.
    Kivilcim M; Peyman GA; El-Dessouky ES; Kazi AA; Cheema R; Hegazy H
    Ophthalmic Surg Lasers; 2000; 31(6):474-8. PubMed ID: 11095124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
    Bucher RS; Hall E; Reed DM; Richards JE; Johnson MW; Zacks DN
    Arch Ophthalmol; 2005 May; 123(5):649-53. PubMed ID: 15883284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
    Kamppeter BA; Cej A; Jonas JB
    Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
    Inoue M; Takeda K; Morita K; Yamada M; Tanigawara Y; Oguchi Y
    Am J Ophthalmol; 2004 Dec; 138(6):1046-8. PubMed ID: 15629301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective effects of intravitreal triamcinolone acetonide and dexamethasone implant in rabbit retinas after pars plana vitrectomy and silicone oil injection.
    Siqueira RC; Dos Santos WF; Scott IU; Messias A; Rosa MN; Fernandes Cunha GM; da Silva Cunha A; Jorge R
    Retina; 2015 Feb; 35(2):364-70. PubMed ID: 25111686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristic of ocular safety profile of triamcinolone made in China].
    Lan B; Hou J; Zhao C; Sun S; Li J; Cheng L
    Zhonghua Yan Ke Za Zhi; 2014 Jul; 50(7):529-35. PubMed ID: 25312463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits.
    McGee DH; Dembinska O; Gruebbel MM
    Int J Toxicol; 2005; 24(6):419-25. PubMed ID: 16393934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further characterization of ocular safety profile of commercially available preserved and preservative-free triamcinolone acetonide.
    Li Y; Chen H; Hou J; Zhang Y; Li G; Gu X; Luo L; Shen H; Qu J; Cheng L
    Retina; 2012 Feb; 32(2):364-74. PubMed ID: 21909054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal toxicity of intravitreal kenalog in albino rabbits.
    Lang Y; Zemel E; Miller B; Perlman I
    Retina; 2007; 27(6):778-88. PubMed ID: 17621190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular toxicity of intravitreal tacrolimus.
    Passos E; Genaidy MM; Peyman GA
    Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal triamcinolone acetonide concentration after subtenon injection.
    Thomas ER; Wang J; Ege E; Madsen R; Hainsworth DP
    Am J Ophthalmol; 2006 Nov; 142(5):860-1. PubMed ID: 17056371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of nontoxic concentrations of piperacillin/tazobactam for intravitreal application. An electroretinographic, histopathologic and morphometric analysis.
    Ozkiriş A; Evereklioglu C; Kontaş O; Oner AO; Erkiliç K
    Ophthalmic Res; 2004; 36(3):139-44. PubMed ID: 15103204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.
    Beer PM; Bakri SJ; Singh RJ; Liu W; Peters GB; Miller M
    Ophthalmology; 2003 Apr; 110(4):681-6. PubMed ID: 12689886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.